QLGN QUALIGEN THERAPEUTICS INC Management Changes 8-K Filing 2024 - Material Definitive Agreement Qualigen Therapeutics, Inc. entered into a Securities Purchase Agreement with an institutional investor for a $2,000,000 loan, issuing a Senior Note with certain terms and characteristics. The agreement also resulted in changes in the company's Board of Directors.Get access to all SEC 8-K filings of the QUALIGEN THERAPEUTICS INC